ArticleOpen medicine (Warsaw, Poland)2026

Early outcomes after focal high-dose-rate brachytherapy in low- and favorable intermediate-risk prostate cancer: promising early results from a prospective randomized trial.

Justinas Jonusas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.